Zhengye Biotechnology Holding (ZYBT) Invested Capital (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Invested Capital data on file, last reported at $52.4 million in Q4 2025.

• Invested Capital for Q4 2025 came in at $52.4 million, down 11.81% year-over-year; the trailing twelve-month figure through Dec 2025 was $52.4 million (down 11.81% YoY), and the FY2025 annual result was $51.7 million, up 5.37% from the prior year.
• Invested Capital advanced to $52.4 million in Q4 2025 per ZYBT's latest filing, from $50.5 million in the prior quarter.
• Over five years, Invested Capital peaked at $59.4 million in Q4 2024 and troughed at $50.5 million in Q2 2025.
• A 3-year average of $55.1 million and a median of $55.3 million in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2024 and 2025: Invested Capital rose 2.11% in 2024, then dropped 11.81% in 2025.
• A 3-year view of Invested Capital shows it stood at $58.2 million in 2023, then advanced by 2.11% to $59.4 million in 2024, then fell by 11.81% to $52.4 million in 2025.
• Business Quant data shows ZYBT's Invested Capital at $52.4 million in Q4 2025, $50.5 million in Q2 2025, and $59.4 million in Q4 2024.